Zika has been downgraded from emergency status by the WHO—and despite how it might sound, Laurie Garrett argues that’s not good news. 

To continue the extraordinary progress of the past fifteen years, the next U.S. administration should further integrate global health, development, and pandemic preparedness into the U.S. national security architecture, write CFR's Thomas J. Bollyky and Eric Goosby, former U.S. AIDS Coordinator and UN Special Envoy on Tuberculosis.

Steve Davis, president and CEO of PATH, and Richard Hatchett, acting director of the Biomedical Advanced Research and Development Authority (BARDA) discuss spurring the development and delivery of medical tools to prepare for emerging infectious disease outbreaks as part of the Global Health, Economics, and Development Roundtable Series.

Dame Sally Davies discusses the challenges of responding to antimicrobial resistance (AMR) and the need for a global action plan following the high level meeting on Antimicrobial Resistance at the United Nations General Assembly.  

Experts discuss the growing crisis of noncommunicable diseases, specifically cardiovascular diseases, and the initiatives by the World Health Organization and the Centers for Disease Control and Prevention in countering these threats globally.

Laurie Garrett writes that the U.N. General Assembly is taking on the danger of antimicrobial resistance that threatens the health of our entire species.

Garrett argues that Congress’ failure to pass a Zika funding bill and the ignored warnings of 9-11 and subsequent anthrax attacks show parallel instances of government failing the American people.

A leading killer among diseases is now targeted for eradication by the middle of this century. This Backgrounder examines the costly, challenging efforts to combat malaria.

Robert E. Litan argues the inevitability of major reform of the Affordable Care Act.

The 2016 Summer Olympics begin in Rio de Janeiro, Brazil, this Friday, August 5. To help better understand the full significance of the Olympic games, the Council on Foreign Relations (CFR) and Foreign Affairs offer resources on the games' political, economic, and health implications for Brazil and the world.

Laurie Garrett writes that politicians in Washington must act now, or bear the blame for Zika’s devastating effects.

The Zika virus is spreading to North America, and U.S. delays in approving research and funding could lead to a public health disaster, write Larry Brilliant and CFR’s Laurie Garrett.

Zika is here, in the USA. Fasten your seat belts because we're in for a bumpy ride.

If a publisher had come to me four months ago and asked me to write a book about the Zika crisis in just 30 days, I’m not sure I would have had the courage to say yes, as Donald G. McNeil Jr. did. So many assumptions written in March or April could prove wrong by June or August that the challenge of quickly producing a book on Zika would seem too risky — given that there will also be sleep deprivation, speed writing, high-velocity editing and rewrite ahead.

Laurie Garrett argues that the stalemate in Congress to fund Zika research places women at dire risk, especially given the CDC's recent announcement of the first documented female to male transmission of the virus in the United States.

As the U.S. campaign season wears on, both Republicans and Democrats are pledging to stay tough on Iran. Such promises aren’t new. Last summer, as the Barack Obama administration unveiled its nuclear agreement, U.S. Secretary of State John Kerry assured skeptics that the United States would sustain essential sanctions that punish Tehran for its aid to terrorists, regional aggression, and human rights abuses.

New waves of nationalism in the U.K., U.S., and Europe could threaten the financing of programs that have saved millions of lives around the world.

In the wake of Ebola and the Zika outbreak, a new book maps out the best, smartest ways to combat man’s greatest killers.

To contain infectious disease outbreaks like Zika and Ebola, global health authorities must learn from past efforts to motivate the private and nonprofit sectors around problems of the poor, write CFR’s Thomas Bollyky and PATH CEO Steve Davis.

Laurie Garrett writes that the organization responsible for international public health is increasing its budget by millions of dollars — but its plan for coming up with the cash to help battle epidemics like Zika isn’t grounded in reality.